Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antidepressant/bröstcancer

Länken sparas på Urklipp
Sida 1 från 290 resultat

Use of antidepressants and the risk of breast cancer: a meta-analysis.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The goal of this study was to perform a meta-analysis to examine the association between the use of antidepressants (AD) and the risk of breast cancer. We searched the EMBASE and MEDLINE databases from inception through February 25, 2012, using search terms related to ADs and breast cancer. Two

Breast cancer risk among users of antidepressant medications.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Breast cancer is the most common cancer in women. Laboratory studies suggest that antidepressants may promote breast cancer tumor growth. Several epidemiologic studies have evaluated this association with conflicting results. METHODS We conducted a cohort study with a secondary nested

Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
In laboratory studies, some antidepressants caused increased growth of mammary tumors. The relation of use of these drugs to the development of breast cancer was examined in a hospital-based case-control study. Information, including lifetime medication history, was collected by interview from 5,814

Use of antidepressant medications and the possible association with breast cancer risk. A review.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Antidepressant medication use has dramatically increased over the past decade, particularly for the newer classes such as selective serotonin reuptake inhibitors. While there is no question about the usefulness of these medications, it is important to review animal and epidemiologic

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Selective serotonin reuptake inhibitors (SSRIs) are a widely prescribed class of antidepressants. Laboratory and epidemiologic evidence suggests that a prolactin-mediated mechanism secondary to increased serotonin levels at neuronal synapses could lead to a potentially carcinogenic effect of SSRIs.

Review of the epidemiological literature on antidepressant use and breast cancer risk.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Based on evidence that antidepressants increase levels of prolactin and may promote the growth of mammary tumor cells, there has been concern that the use of these drugs may increase the risk of breast cancer. This article reviews the epidemiological evidence on the relationship between breast

Relationship between antidepressant prescription and breast cancer: a population based study in Taiwan.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
To investigate the association between antidepressant prescription and breast cancer. The National Health Research Institute in Taiwan provided a database of 1 000 000 random subjects for this study. We identified 14 737 new antidepressant female users who were more than 15 years old during

ReCAP: Would Women With Breast Cancer Prefer to Receive an Antidepressant for Anxiety or Depression From Their Oncologist?

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE Patient treatment preferences for the management of anxiety and depression influence adherence to treatment and treatment outcomes, yet the preferences of patients with breast cancer for provider-specific pharmacologic management of anxiety and depression is unknown. This study examined

Depression, Antidepressant Use, and Breast Cancer Risk in Pre- and Postmenopausal Women: A Prospective Cohort Study.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Background: Depression and antidepressant use is highly prevalent among U.S. women and may be related to increased breast cancer risk. However, prior studies are not in agreement regarding an increase in risk.Methods: We conducted a prospective cohort study within the Nurses' Health Study (NHS) and

Antidepressant use and the risk of breast cancer: a non-association.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE Animal studies have suggested that some antidepressant medications may act as breast tumor promoters and recent epidemiologic studies of antidepressant use and breast cancer outcomes in humans have also reported such associations. METHODS Retrospective cohort study. METHODS 38,273 women

[Antidepressants agents in breast cancer patients using tamoxifen: review of basic and clinical evidence].

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Tamoxifen (Tmf), is a standard of care for women with estrogen receptor positive (ER+) breast cancer. Endoxifen is a Tmf metabolite generated by cytochrome P450 2D6 (CYP2D6). Antidepressive agents (AD) are often prescribed to women with breast cancer not only for depression, but also for anxiety and

[Antagonism of tamoxifen and antidepressants among women with breast cancer].

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Tamoxifen is used as an adjuvant therapy to reduce breast cancer recurrence among women with estrogen receptor positive tumors. Antidepressants are also commonly used in such women, to treat depression or to manage hot flushes, a frequent tamoxifen secondary effect. Some antidepressants could

Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE Long-term treatment with antidepressants can lessen the symptoms of depression, but health-related crises-such as a cancer diagnosis-may disrupt ongoing depression care. The study aims to estimate the effect of receiving a breast cancer diagnosis on antidepressant adherence among women

Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Whether depression and antidepressant (AD) use might influence breast cancer risk is unclear, and these exposures have not been evaluated together in a single, prospective cohort study of breast cancer risk. METHODS Among 71,439 postmenopausal women in the Women's Health Initiative

Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE In 2002, we reported an epidemiological study in which we found that some tricyclic antidepressants (identified as genotoxic in Drosophila Melanogaster) were associated with an increased risk of breast cancer, when exposure took place 11-15 years before the date of diagnosis. The
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge